Fetal-maternal haemorrhage

From Wikipedia, the free encyclopedia
  (Redirected from Fetal-maternal hemorrhage)
Jump to: navigation, search
"FMH" redirects here. For the blog, see Feminist Mormon Housewives.
Fetal-maternal haemorrhage
Classification and external resources
ICD-10 P50.4
ICD-9 656.0, 772.0

Fetal-maternal haemorrhage is the loss of fetal blood cells into the maternal circulation. It takes place in normal pregnancies as well as when there are obstetric or trauma related complications to pregnancy.

Normally the maternal circulation and the fetal circulation are kept from direct contact with each other, with gas and nutrient exchange taking place across a membrane in the placenta made of two layers, the syncytiotrophoblast and the cytotrophoblast. Fetal-maternal haemorrhage occurs when this membrane ceases to function as a barrier and fetal cells may come in contact with and enter the maternal vessels in the decidua/endometrium.

Description[edit]

Normal Pregnancy[edit]

It is estimated that less than 1 mL of fetal blood is lost to the maternal circulation during normal labour in around 96% of normal deliveries.[1][2] The loss of this small amount of blood may however be a sensitising event and stimulate antibody production to the fetal red blood cells, an example of which is Rhesus disease of the newborn.

Abnormal Pregnancy[edit]

Causes of increased fetal-maternal haemorrhage are seen as a result of trauma, placental abruption or may be spontaneous with no cause found.

Up to 30 mL of fetal-maternal transfusion may take place with no significant signs or symptoms seen in either mother or fetus.[3] Loss in excess of this may result in significant morbidity and mortality to the fetus. Fetal-maternal haemorrhage is one cause of intrauterine death (IUD).

Diagnosis[edit]

Kleihauer test, showing fetal red blood cells in rose-pink color, while adult red blood cells are only seen as "ghosts".

The Kleihauer–Betke test is a blood test used to measure the amount of fetal hemoglobin transferred from a fetus to its mother's bloodstream.[4] It takes advantage of the differential resistance of fetal hemoglobin to acid. A standard blood smear is prepared from the mother's blood, and exposed to an acid bath. This removes adult hemoglobin, but not fetal hemoglobin, from the red blood cells. Subsequent staining, using Shepard's method,[5] makes fetal cells (containing fetal hemoglobin) appear rose-pink in color, while adult red blood cells are only seen as "ghosts". 2000 cells are counted under the microscope and a percentage of fetal to maternal cells is calculated.

Fetal-maternal haemorrhage can also be diagnosed by flow cytometry, using anti-fetal hemoglobin antibodies (anti-HbF).[6]

Treatment[edit]

If ongoing and rapid haemorrhage is occurring then immediate delivery of the fetus may be indicated if the fetus is sufficiently developed.[7] If the haemorrhage has already occurred and now stopped, an inutero transfusion of red cells to the foetus may be recommended.[8]

References[edit]

  1. ^ Sebring ES, Polesky HF. Fetomaternal Hemorrhage: Incidence, risk factors, time of occurrence, and clinical effects" Transfusion 1990; 30:344-357.
  2. ^ Medearis AL, Hensleigh Pa, Parks DR, Herzenberh LA. Detection of foetal erythrocytes in maternal blood post partum with the fluorescence-activated cell sorter. American Journal of Obstetrics and Gynaecology 1984; 48:290-295.
  3. ^ Polesky HF Sebring ES. Evaluation of methods of detection and quantitation of fetal cells and their effects on Rh Ig usage. American Journal of Clinical Pathology 198 1; 76(suppl):525-529.
  4. ^ Katiyar R, Kriplani A, Agarwal N, Bhatla N, Kabra M (2007). "Detection of fetomaternal hemorrhage following chorionic villus sampling by Kleihauer–Betke test and rise in maternal serum alpha feto protein". Prenat. Diagn. 27 (2): 139–42. doi:10.1002/pd.1632. PMID 17191260. 
  5. ^ Alcoholic haematoxylin, acidified ferric chloride, Shepard's counterstain. Shepard's Fixative/Diluent
  6. ^ Kim, Yeowon A.; Makar, Robert S. (2012). "Detection of fetomaternal hemorrhage". American Journal of Hematology 87 (4): 417–423. doi:10.1002/ajh.22255. ISSN 0361-8609. PMID 22231030. 
  7. ^ Massive fetomaternal hemorrhage and oxytocin contraction test: case report and review Arch Gynecol Obstet. 2004 Jan ;269 (2):149-51 14648183 (P,S,G,E,B)
  8. ^ Massive fetomaternal hemorrhage and oxytocin contraction test: case report and review Arch Gynecol Obstet. 2004 Jan ;269 (2):149-51 14648183 (P,S,G,E,B)